SCHEMBL8941438

SCHEMBL8941438

CC(C1CC(c2ccc(F)cc2)=NO1)N(O)C(N)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.50
APAF1 O14727 1/20 0.50
GRK2 P25098 1/20 0.50
APOBEC3G Q9HC16 1/20 0.50
RAB9A P51151 6/20 0.44
MAPK10 P53779 5/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
CYP2C19 P33261 3/20 0.44
NPC1 O15118 3/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2C9 P11712 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
CASP1 P29466 1/20 0.44
CYP1A2 P05177 2/20 0.43
MAPT P10636 4/20 0.42
ALDH1A1 P00352 5/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HTT P42858 2/20 0.40
LMNA P02545 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8941420 0.88 MIF (0.38) POLBAPAF1GRK2APOBEC3GRAB9A
SCHEMBL8941571 0.88 ALOX5 (0.47) POLBRAB9AMEN1KMT2ACYP2C19
SCHEMBL8941440 0.87 HTT (0.47) POLBAPAF1GRK2APOBEC3GNPC1
SCHEMBL8941576 0.83 ALOX5 (0.48) POLBRAB9AMEN1KMT2ACYP2C19
SCHEMBL8941414 0.81 F10 (0.42) SMN1; SMN2CYP1A2MAPTALDH1A1LMNA
SCHEMBL21066152 0.77 POLB (0.53) POLBAPAF1GRK2APOBEC3GRAB9A
SCHEMBL8941751 0.76 ALOX5 (0.53) RAB9AMAPK10CYP2C19NPC1CYP3A4
SCHEMBL8941462 0.74 PPARG (0.44) POLBAPAF1GRK2APOBEC3GRAB9A
SCHEMBL8941375 0.74 ALOX5 (0.46) POLBAPAF1GRK2APOBEC3GRAB9A
SCHEMBL8941395 0.72 POLB (0.52) POLBAPAF1GRK2APOBEC3GRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5552424-A Isoxazolines as antiinflammatory agents PFIZER INC. (US) 1996-09-03 US disclosed